Patents by Inventor Daniel C. Williams

Daniel C. Williams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11910870
    Abstract: An upper for an article of footwear may include one or more of the following: a knitted component forming a collar of the upper, the collar at least partially forming an opening for providing access to an interior of the article of footwear; and a first knit edge and a second knit edge that extend along the collar of the upper, wherein a knitted central portion of the collar extends between the first knit edge and the second knit edge. The collar may consist of a single seam to join together the first knit edge and the second knit edge. The single seam may be offset from a centerline at the rear-most portion of a heel area such that the knitted central portion of the collar extends through the centerline of the heel area.
    Type: Grant
    Filed: July 31, 2020
    Date of Patent: February 27, 2024
    Assignee: NIKE, Inc.
    Inventors: Daniel A. Podhajny, Benjamin A. Shaffer, Erin E. Toraya, Robert C. Williams, Jr.
  • Publication number: 20100160217
    Abstract: The present invention provides receptor chaperons and means for producing cells having increased and/or decreased expression of nAChR subunit combinations and/or nAChR subtypes, which provide useful models for investigating pharmacological properties of the receptors and regulation of the binding sites of potential nAChR subtypes.
    Type: Application
    Filed: May 4, 2006
    Publication date: June 24, 2010
    Inventors: Daniel C Williams, Erik M. Jorgensen
  • Patent number: 5418252
    Abstract: A method of inhibiting cartilage degradation comprising administering to a human or other mammal in need of treatment an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidino and piperidino, a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: October 15, 1993
    Date of Patent: May 23, 1995
    Assignee: Eli Lilly and Company
    Inventor: Daniel C. Williams